Avivagen Inc. announced the completion of a trial testing OxC-betaTM Livestock 10% in gestating­lactating sows, conducted by South China Agricultural University located in Guangzhou, China. Results from the independent study demonstrated that OxC-beta not only benefited sow health but also led to improvements in the health of nursing piglets. Of particular note, OxC-beta-supplemented sows showed less weight loss during lactation and had litters that were 6-7% heavier at weaning compared to sows in the non-supplemented control group. Piglet-weight at weaning is a well-known indicator of future good health and growth performance. Furthermore, in the OxC-beta treated groups there was a 5-6% increase in the number of sows returning to estrus within 7 days post-lactation compared to control, an indication that sows receiving OxC-beta recovered faster following lactation. Analysis of sow milk revealed a significant increase in milk-lactose content and dose-dependent trends for increased fat, protein and non-fat solids in the OxC-beta-supplemented sows. These improvements in the nutritional content of sow's milk likely contributed to the improved health and growth of the nursing piglets.